Gufic BioSciences Declines 11.33% Amid Mixed Technical Signals and Market Pressure
2026-11-22 09:01:09Key Events This Week 16 Nov: Intraday low hit amid price pressure, closing at Rs.440.95 (-6.49%) 16 Nov: Q2 FY27 results reveal strong revenue growth but valuation concerns 19 Nov: Technical momentum shifts with mixed indicator signals, stock closes at Rs.424.10 (-3.26%) 20 Nov: Bullish momentum emerges amid technical upgrades, closing at Rs.432.50 (+1.98%) Week OpenRs.471.55 ...
Read More
Gufic BioSciences Ltd Shows Bullish Momentum Amid Technical Upgrades
2026-11-20 08:01:00Gufic BioSciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by improvements across key technical indicators including moving averages, Bollinger Bands, and the MACD, signalling renewed investor interest in this small-cap pharmaceutical and biotechnology player.
Read More
Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-11-19 08:01:43Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. While the company’s Mojo Grade has improved from Sell to Hold as of 29 June 2026, recent price movements and technical indicators reveal a complex interplay of bullish and bearish signals that investors should carefully analyse.
Read More
Gufic BioSciences Ltd Hits Intraday Low Amid Price Pressure on 16 Nov 2026
2026-11-16 09:32:48Gufic BioSciences Ltd experienced a notable intraday decline on 16 Nov 2026, touching a low of Rs 400.65, down 15.04% from previous levels, reflecting significant price pressure despite a broadly positive market environment.
Read MoreGufic BioSciences Surges 9.79%: Four Key Drivers Behind This Week’s Rally
2026-11-15 09:00:06Key Events This Week 09 Nov: New 52-week high at Rs.467.7 and intraday peak of Rs.475 with an 8.41% surge 11 Nov: Fresh 52-week high at Rs.492.75 and strong technical momentum confirmed 12 Nov: Price rebound to Rs.485.75 (+3.73%) after minor dip 13 Nov: Week closes at Rs.471.55 (-2.92%) amid profit-taking Week OpenRs.429.50 <div class="stat-label"...
Read More
Gufic BioSciences Ltd Surges 8.41% to Day's High of Rs 475 — Outperforms Sector by 6.49 Percentage Points
2026-11-09 15:31:44The Sensex edged up a modest 0.13% on 09 Nov 2026, while Gufic BioSciences Ltd surged 8.41%, hitting an intraday high of Rs 475. This 6.49 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific strength rather than a broad market lift.
Read More
Broad-Based Technical Strength Lifts Gufic BioSciences Ltd to 52-Week High of Rs 467.7
2026-11-09 10:35:38Surging past its previous peaks, Gufic BioSciences Ltd touched a fresh 52-week high of Rs 467.7 on 09 Nov 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained buying interest, setting the stage for a notable rally in the pharmaceuticals sector.
Read More
Gufic BioSciences Ltd is Rated Hold by MarketsMOJO
2026-11-09 10:10:40Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. While the rating change occurred mid-year, the analysis and financial metrics presented here reflect the stock's current position as of 09 November 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read More
Gufic BioSciences Ltd is Rated Hold by MarketsMOJO
2026-10-29 10:11:30Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
20-Nov-2026 | Source : BSEWritten Transcript of Earnings Conference Call held on November 16 2026 at 04:30 p.m. is attached herewith
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSENewspaper advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2026 is attached herewith
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16-Nov-2026 | Source : BSEIntimation of Audio Recording of Earnings Conference Call held on November 16 2026 at 04:30 p.m. is attached herewith
Corporate Actions
No Upcoming Board Meetings
Gufic BioSciences Ltd has declared 10% dividend, ex-date: 28 Aug 26
No Splits history available
No Bonus history available
No Rights history available